EUVIMEDEUVIMED entdecken
Crossref

Prevalence of Multidrug-Resistant Tuberculosis at a Regional Drug-Resistant Tuberculosis Center of Maharashtra

Gauri Suhas Kulkarni, Supriya Dhakne Palwe, Nilesh P. Patil, Abhijit J. Telkhade, Jui Kadukar

Indian Journal of Respiratory Care · 2020

DOI: 10.4103/ijrc.ijrc_10_19 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indian Journal of Respiratory Care, 2020. Verfasst von Gauri Suhas Kulkarni und 4 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 19 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Multidrug-resistant tuberculosis (MDR-TB) has created a significant health problem in most of the countries, and it is an obstacle to effective TB control. Aims and Objectives: The study aims to study the prevalence of MDR-TB among new cases, retreatment cases and to study the rate of MDR-TB detection among suspected cases of Category I (CAT I) failure, CAT II failure and at the start of CAT II. Patients and Methods: The present retrolective study was conducted by reviewing the records of diagnosed MDR-TB patients at a drug-resistant TB center from January 2012 to December 2013. The data of new and retreatment pulmonary TB (PTB) cases diagnosed during that period were collected. The data were analyzed to find out the prevalence of MDR-TB, and the rate of MDR-TB detected among each CAT.

Results

The prevalence of MDR-TB in new cases was 0.10% and that of retreatment cases was 4.3%. The rate of MDR-TB detection among suspected cases of CAT I failure was 16.8%, 52.4% in CAT II failure, 11.6% at the start of CAT II, 11.7% among sputum positive during any month follow-up, 6.6% among MDR-TB contacts.

Conclusion

Timely suspicion and diagnosis of MDR-TB and treatment are important in new and retreatment cases. All relapse or defaulter patients should be screened for MDR-TB at the start of CAT II treatment. MDR-TB should be suspected in any sputum-positive TB patient during treatment/sputum positive relapse/defaulter PTB.

Zitieren

APA

Kulkarni, G. S., Palwe, S. D., Patil, N. P., Telkhade, A. J., & Kadukar, J. (2020). Prevalence of Multidrug-Resistant Tuberculosis at a Regional Drug-Resistant Tuberculosis Center of Maharashtra. Indian Journal of Respiratory Care. https://doi.org/10.4103/ijrc.ijrc_10_19

Vancouver

Kulkarni GS, Palwe SD, Patil NP, Telkhade AJ, Kadukar J. Prevalence of Multidrug-Resistant Tuberculosis at a Regional Drug-Resistant Tuberculosis Center of Maharashtra. Indian Journal of Respiratory Care. 2020. doi:10.4103/ijrc.ijrc_10_19

BibTeX
@article{Kulkarni2020,
  author = {Kulkarni, Gauri Suhas and Palwe, Supriya Dhakne and Patil, Nilesh P. and Telkhade, Abhijit J. and Kadukar, Jui},
  title = {Prevalence of Multidrug-Resistant Tuberculosis at a Regional Drug-Resistant Tuberculosis Center of Maharashtra},
  journal = {Indian Journal of Respiratory Care},
  year = {2020},
  doi = {10.4103/ijrc.ijrc_10_19}
}
Kostenlos starten →